Proficiency testing linked to the national reference system for the clinical laboratory: a proposal for achieving accuracy.
I propose using proficiency testing (PT) to achieve one of the important goals of CLIA: accurate and reliable clinical testing. Routine methods for the clinical laboratory are traceable to Definitive (DM) or Reference Methods (RM) or to Methodological Principles (MP) through a modification of the National Reference System for the Clinical Laboratory. PT is the link used to monitor consistent field performance. Although PT has been effective as a relative measure of laboratory performance, the technical limitations of PT fluids and of routine methods currently in use make it unlikely that PT alone can be used as a reliable measure of laboratory accuracy. Instead, I recommend calibration of routine systems through correlation to DM, RM, or MP with use of patients' specimens. The manufacturer is in the best position to assume this responsibility because of also being responsible for consistent, reliable product. Analysis of different manufactured batches of reagent would be compared with predetermined goals for precision and accuracy, as illustrated with data from product testing of Kodak Ektachem clinical chemistry slides. Adoption of this proposal would give manufacturers of PT materials, manufacturers of analytical systems, PT providers, and government agencies time to understand and resolve sources of error that limit the utility of PT for the job required by law.
Lasky
F D
FD
Clinical Products Division, Eastman Kodak Company, Rochester, NY 14650-1252.
D002624:Chemistry, Clinical / Q000331:legislation & jurisprudence / Q000592:standards*; D006801:Humans; D007753:Laboratories / Q000331:legislation & jurisprudence / Q000592:standards*; D008004:Licensure / Q000331:legislation & jurisprudence; D011786:Quality Control; D012015:Reference Standards